New! Sign up for our free email newsletter.
Science News
from research organizations

New insight into the cellular defects in Huntington's disease

Date:
October 11, 2011
Source:
Journal of Clinical Investigation
Summary:
Huntington disease is a devastating neurogenerative disorder caused by a mutant HTT gene. Although this has been known for many years, the functions of normal Htt protein and the mechanisms by which mutant Htt protein causes disease are not well understood. But now, researchers have now uncovered a new function for normal Htt protein and determined that this function is disrupted in a mouse model of Huntington's disease and in patients with the disorder.
Share:
FULL STORY

Huntington disease is a devastating neurogenerative disorder that causes a progressive loss of functional capacity and reduced life span. It is an inherited condition caused by a mutant HTT gene. Although this has been known for many years, the functions of the normal Htt protein and the mechanisms by which the mutant protein generated from the mutant HTT gene causes disease are not well understood.

A team of researchers led by Frédéric Saudou, at the Institut Curie, France, has now uncovered a new function for normal Htt protein and determined that this function is disrupted in a mouse model of Huntington disease and in patients with the disorder.

Detailed analysis by Saudou and colleagues determined that normal Htt protein regulates the formation of cellular structures known as cilia and that cilia were longer and disorganized in the mouse model of Huntington disease and patients. They therefore suggest that abnormal cilia could be a cause of some of the symptoms of Huntington disease. However, they also caution that further studies are needed to prove this. This point is also made in an accompanying commentary by Scott Zeitlin and Jeh-Ping Liu, at the University of Virginia, Charlottesville, who go on to note that determining this is critical to discerning whether therapeutic strategies designed to normalize ciliary function could ameliorate the symptoms of Huntington disease.


Story Source:

Materials provided by Journal of Clinical Investigation. Note: Content may be edited for style and length.


Journal Reference:

  1. Guy Keryer, Jose R. Pineda, Géraldine Liot, Jinho Kim, Paula Dietrich, Caroline Benstaali, Karen Smith, Fabrice P. Cordelières, Nathalie Spassky, Robert J. Ferrante, Ioannis Dragatsis, Frédéric Saudou. Ciliogenesis is regulated by a huntingtin-HAP1-PCM1 pathway and is altered in Huntington disease. Journal of Clinical Investigation, 2011; DOI: 10.1172/JCI57552

Cite This Page:

Journal of Clinical Investigation. "New insight into the cellular defects in Huntington's disease." ScienceDaily. ScienceDaily, 11 October 2011. <www.sciencedaily.com/releases/2011/10/111010122142.htm>.
Journal of Clinical Investigation. (2011, October 11). New insight into the cellular defects in Huntington's disease. ScienceDaily. Retrieved March 18, 2024 from www.sciencedaily.com/releases/2011/10/111010122142.htm
Journal of Clinical Investigation. "New insight into the cellular defects in Huntington's disease." ScienceDaily. www.sciencedaily.com/releases/2011/10/111010122142.htm (accessed March 18, 2024).

Explore More

from ScienceDaily

RELATED STORIES